George Eastwood

Board Chair, Interim Executive Director • Emily Whitehead Foundation

Experienced Chief Commercial Officer with a proven track record in the cell and gene therapy industry. Dedicated to addressing challenges in developing and manufacturing cell-based therapeutics, particularly focusing on cGMP materials. Committed to advancing these therapies as a priority, both in my professional role and through my involvement with The Emily Whitehead Foundation.

Also speaking

Ohad Karnieli

Founder & Chief Executive Officer • Adva Biotechnology

Ruud Das

Chief Scientific Officer • Scinus Cell Expansion Netherlands B.V

Thomas Bols

Head of Government Affairs and Patient Advocacy, EMEA • PTC Therapeutics

Event Info


Advanced Therapies Investment Summit

Find out more about the Investor Pre-Day taking place 10th September 2024.

2023 Sample Attendee List

Take a look at the sample attendee list for Advanced Therapies Europe 2023 here.